Evidence map›Paper›PMID 42359547›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026

Ongoing multi-country outbreak of carbapenem-resistant

Louise Roer, Mirco Sandfort, Sebastian Haller, Sarah A Roth, Lisa-Marie Höfken, Soheila Javadi, Núria Balanza, Amelie Friedsam, Silver A Wolf, Claus Østergaard and 24 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Louise RoerNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Mirco SandfortThese authors contributed equally to this work and share first authorship.
Sebastian HallerDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Sarah A RothPublic Health Agency of Lower Saxony (NLGA), Hanover, Germany.
Lisa-Marie HöfkenGerman National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Soheila JavadiGerman National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
Núria BalanzaCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Amelie FriedsamDepartment of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Silver A WolfGenome Competence Centre (MF 1), Robert Koch Institute, Berlin, Germany.
Claus ØstergaardDepartment of Clinical Microbiology, Lillebaelt Hospital, Vejle, Denmark.
Monica T Y WongCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Joanna Lis-TønderDepartment of Clinical Microbiology, Lillebaelt Hospital, Vejle, Denmark.
Annelot F SchoffelenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Martin CormicanSchool of Medicine, University of Galway, Galway, Ireland.
Lone Jannok PorsboNational Center for Infection Control, Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Copenhagen, Denmark.
Christina ClarkeGalway Reference Laboratory Service, Galway, Ireland.
Henrik HasmanNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Heidrun KerschnerNational Reference Center for Antimicrobial Resistance, Linz, Austria.
Anette M HammerumNational Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Rainer HartNational Reference Center for Antimicrobial Resistance, Linz, Austria.
Ørjan SamuelsenNorwegian Centre for Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
Miriam SareDepartment of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway.
Marie MeoLaboratoire National de Santé, Dudelange, Luxembourg.
Anne-Sophie LagneauxLaboratoire National de Santé, Dudelange, Luxembourg.
Monique PerrinLaboratoire National de Santé, Dudelange, Luxembourg.
Vilhelm MüllerPublic Health Agency of Sweden, Solna, Sweden.
Sandra WitteveenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Sabine C de GreeffCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Daan W NotermansCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Olov SvartströmEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Erik AlmEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Marius LinkeviciusEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Anke KohlenbergEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Antoni P A HendrickxCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In seven EU/EEA countries, the emergence of NDM-5-producing

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCarbapenemsDisease OutbreaksEnterobacterEnterobacteriaceae InfectionsAgedAged, 80 and overEuropeEuropean UnionFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial Agentsbeta-LactamasesCarbapenems“carbapenemase”“carbapenem-resistant Enterobacterales”“cross-border spread”“disease outbreaks”“drug resistance, bacterial”New Delhi metallo-β-lactamase“surveillance”

Identifiers

PMID42359547
PMCPMC13309760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.